Corteva Inc's Preferred Stock Dividend History Analysis
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 30 2026
0mins
Source: NASDAQ.COM
- Dividend History Overview: Corteva Inc's preferred stock (CTA.PRB) recently declared a dividend of $1.125 per share, indicating the company's stability in dividend payments and reflecting its financial health.
- ETF Holdings Insight: According to ETF Finder, Corteva Inc comprises 47.66% of the AGF U.S. Market Neutral Anti-Beta Fund ETF (BTAL), highlighting its significance in the market and investor confidence.
- Stock Performance: In Tuesday trading, Corteva Inc's preferred shares rose approximately 0.6%, while common shares (CTVA) increased about 1.6%, showcasing investor optimism regarding the company's future performance.
- Market Stability: Despite overall market fluctuations, both Corteva's preferred and common stocks exhibited relatively stable growth, reflecting the company's resilience in an uncertain market environment.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CTVA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CTVA
Wall Street analysts forecast CTVA stock price to fall
13 Analyst Rating
9 Buy
4 Hold
0 Sell
Moderate Buy
Current: 86.390
Low
77.00
Averages
83.75
High
89.00
Current: 86.390
Low
77.00
Averages
83.75
High
89.00
About CTVA
Corteva, Inc. is a provider of seed and crop protection solutions. The Company is focused on progressing science-based innovations which deliver a range of agriculture products and services to customers. Its segments include Seed and Crop Protection. The Seed segment is engaged in developing and supplying commercial seed combining germplasm and traits that offer yield for farmers. It offers seed and trait technologies that boost resilience to weather, pests, diseases, and herbicides used to manage weeds. Its brands include Pioneer seeds, Brevant seeds, Dairyland Seed, Hoegemeyer hybrids and Nutech seed. The Crop Protection segment serves the agricultural input industry with products that protect against weeds, insects and other pests, and disease, and that support overall crop health both above and below ground via nitrogen management and seed-applied technologies. It offers herbicides, insecticides, nitrogen stabilizers, pasture and range management herbicides.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Corteva Partners with Arevo to Launch Innovative Soy Crop Nutrition System
- Partnership Announcement: Corteva has partnered with Swedish company Arevo to launch Arginex Soy, an arginine-based seed treatment system designed to strengthen soybean root systems, enhance nodulation, and improve crop yields and resilience, thereby promoting more sustainable agricultural practices.
- Technical Evaluation: Following a multi-stage technical evaluation, Arginex Soy has been confirmed to deliver measurable crop performance benefits while seamlessly integrating into Corteva's existing soybean seed treatment portfolio, reducing barriers for farmers to adopt this new technology.
- Market Integration: The product is already available to farmers in Europe, and Corteva is incorporating it into its soybean seed treatment offerings to help crops achieve the best start and improve nutrient use efficiency from the earliest growth stages.
- Industry Impact: Leonardo Costa, EMEA Seed Applied Technologies Leader at Corteva, stated that the consistency and stability of Arginex Soy provide farmers with a practical solution to support early crop establishment, marking an important milestone for Arevo in the agricultural technology sector.
See More
Corteva Inc's Preferred Stock Dividend History Analysis
- Dividend History Overview: Corteva Inc's preferred stock (CTA.PRB) recently declared a dividend of $1.125 per share, indicating the company's stability in dividend payments and reflecting its financial health.
- ETF Holdings Insight: According to ETF Finder, Corteva Inc comprises 47.66% of the AGF U.S. Market Neutral Anti-Beta Fund ETF (BTAL), highlighting its significance in the market and investor confidence.
- Stock Performance: In Tuesday trading, Corteva Inc's preferred shares rose approximately 0.6%, while common shares (CTVA) increased about 1.6%, showcasing investor optimism regarding the company's future performance.
- Market Stability: Despite overall market fluctuations, both Corteva's preferred and common stocks exhibited relatively stable growth, reflecting the company's resilience in an uncertain market environment.
See More
Corteva Plans Separation by Q4 2026 with New Board Leadership
- Board Leadership Change: Corteva has announced that Greg Page will serve as the Independent Chair of the new nine-member board, effective upon the planned separation in Q4 2026, ensuring continuity and stability in governance with most existing directors remaining in place.
- Core Operational Efficiency: The new Corteva will focus on operational efficiency, aiming to drive business growth through differentiated innovation, and is expected to leverage its technological leadership to deliver value to farmers, enhancing its competitive position in the market.
- Investment and Growth Strategy: The company intends to make targeted investments to support growth and leverage its first-mover advantage in nature-inspired technologies, pursuing opportunities that promise attractive returns in differentiated markets, thereby enhancing overall profitability.
- Future Outlook: Corteva is committed to maximizing productivity for farmers through its unique distribution strategy and a globally diverse mix of seed, crop protection, and digital products, ensuring long-term sustainable development and innovation in the agricultural sector.
See More
Corteva Announces Vylor Board Members Ahead of 2026 Separation
- Board Leadership: Karen Grimes will serve as the Independent Chair of Vylor's board, bringing extensive investment management experience since joining Corteva's board in March 2021, which is expected to provide crucial strategic guidance for the new company.
- Separation Progress: Corteva is on track to complete the separation of Vylor in Q4 2026, with board member appointments effective at that time, indicating a clear roadmap for the company's future development.
- Innovation Focus: Vylor will leverage advanced seed and genetics expertise, planning to enhance its core business through gene editing and molecular breeding, while exploring opportunities in new row crops to strengthen its market position.
- Market Expansion Strategy: Vylor aims to scale innovations by significantly expanding its licensing business and optimizing routes-to-market, which will not only enhance the company's market share but also deliver more efficient solutions to the agriculture sector.
See More
Corteva Plans Separation for Q4 2026 with New Board Leadership
- Board Leadership Change: Corteva has announced that Greg Page will serve as the Independent Chair of the new nine-member board, effective upon the planned separation in Q4 2026, ensuring continuity and stability in governance as four existing directors will remain on the board.
- Innovation-Driven Strategy: The new Corteva will focus on innovation, leveraging its technological leadership to optimize its product portfolio and operating model, aiming to provide high-value solutions for farmers while maintaining an asset-light, efficient business to tackle agricultural market challenges.
- Market Positioning and Investment: Corteva plans to make targeted investments to support growth and leverage its first-mover advantage in nature-inspired technologies, pursuing opportunities that promise attractive returns in differentiated markets, thereby enhancing its competitive position.
- Forward-Looking Statement Risks: Corteva's forward-looking statements highlight various risks associated with the separation process, including potential distractions for management and possible litigation, which could impact the company's operational results and business development, necessitating careful consideration.
See More
FMC and Corteva Forge Strategic Supply Agreement
- Strategic Partnership: FMC and Corteva's strategic supply and license agreement will expand the application of rimisoxafen technology across North and South American corn and soybean markets, significantly enhancing farmers' ability to combat herbicide-resistant weeds, particularly the Amaranthus species, which poses a major threat to soybean crops.
- Market Potential Unlocked: Corteva's initial $200 million pre-purchase payment for rimisoxafen ensures a steady supply, and the introduction of this innovative technology is expected to help farmers improve productivity and profitability, reflecting both companies' confidence in future market demand.
- Dual Mode of Action: Rimisoxafen's dual mode of action creates a significantly higher barrier to resistance development, effectively managing multiple-resistant weeds like palmer amaranth and waterhemp, which cost farmers billions in lost yields annually.
- Future Outlook: Over the next decade, FMC plans to continue developing additional rimisoxafen-based products, further solidifying its core position in global agricultural innovation while promoting rapid adoption of this technology to meet long-term farmer needs.
See More
Corteva Partners with Arevo to Launch Innovative Soy Crop Nutrition System
- Partnership Announcement: Corteva has partnered with Swedish company Arevo to launch Arginex Soy, an arginine-based seed treatment system designed to strengthen soybean root systems, enhance nodulation, and improve crop yields and resilience, thereby promoting more sustainable agricultural practices.
- Technical Evaluation: Following a multi-stage technical evaluation, Arginex Soy has been confirmed to deliver measurable crop performance benefits while seamlessly integrating into Corteva's existing soybean seed treatment portfolio, reducing barriers for farmers to adopt this new technology.
- Market Integration: The product is already available to farmers in Europe, and Corteva is incorporating it into its soybean seed treatment offerings to help crops achieve the best start and improve nutrient use efficiency from the earliest growth stages.
- Industry Impact: Leonardo Costa, EMEA Seed Applied Technologies Leader at Corteva, stated that the consistency and stability of Arginex Soy provide farmers with a practical solution to support early crop establishment, marking an important milestone for Arevo in the agricultural technology sector.
See More
Corteva Inc's Preferred Stock Dividend History Analysis
- Dividend History Overview: Corteva Inc's preferred stock (CTA.PRB) recently declared a dividend of $1.125 per share, indicating the company's stability in dividend payments and reflecting its financial health.
- ETF Holdings Insight: According to ETF Finder, Corteva Inc comprises 47.66% of the AGF U.S. Market Neutral Anti-Beta Fund ETF (BTAL), highlighting its significance in the market and investor confidence.
- Stock Performance: In Tuesday trading, Corteva Inc's preferred shares rose approximately 0.6%, while common shares (CTVA) increased about 1.6%, showcasing investor optimism regarding the company's future performance.
- Market Stability: Despite overall market fluctuations, both Corteva's preferred and common stocks exhibited relatively stable growth, reflecting the company's resilience in an uncertain market environment.
See More
Corteva Plans Separation by Q4 2026 with New Board Leadership
- Board Leadership Change: Corteva has announced that Greg Page will serve as the Independent Chair of the new nine-member board, effective upon the planned separation in Q4 2026, ensuring continuity and stability in governance with most existing directors remaining in place.
- Core Operational Efficiency: The new Corteva will focus on operational efficiency, aiming to drive business growth through differentiated innovation, and is expected to leverage its technological leadership to deliver value to farmers, enhancing its competitive position in the market.
- Investment and Growth Strategy: The company intends to make targeted investments to support growth and leverage its first-mover advantage in nature-inspired technologies, pursuing opportunities that promise attractive returns in differentiated markets, thereby enhancing overall profitability.
- Future Outlook: Corteva is committed to maximizing productivity for farmers through its unique distribution strategy and a globally diverse mix of seed, crop protection, and digital products, ensuring long-term sustainable development and innovation in the agricultural sector.
See More
Corteva Announces Vylor Board Members Ahead of 2026 Separation
- Board Leadership: Karen Grimes will serve as the Independent Chair of Vylor's board, bringing extensive investment management experience since joining Corteva's board in March 2021, which is expected to provide crucial strategic guidance for the new company.
- Separation Progress: Corteva is on track to complete the separation of Vylor in Q4 2026, with board member appointments effective at that time, indicating a clear roadmap for the company's future development.
- Innovation Focus: Vylor will leverage advanced seed and genetics expertise, planning to enhance its core business through gene editing and molecular breeding, while exploring opportunities in new row crops to strengthen its market position.
- Market Expansion Strategy: Vylor aims to scale innovations by significantly expanding its licensing business and optimizing routes-to-market, which will not only enhance the company's market share but also deliver more efficient solutions to the agriculture sector.
See More
Corteva Plans Separation for Q4 2026 with New Board Leadership
- Board Leadership Change: Corteva has announced that Greg Page will serve as the Independent Chair of the new nine-member board, effective upon the planned separation in Q4 2026, ensuring continuity and stability in governance as four existing directors will remain on the board.
- Innovation-Driven Strategy: The new Corteva will focus on innovation, leveraging its technological leadership to optimize its product portfolio and operating model, aiming to provide high-value solutions for farmers while maintaining an asset-light, efficient business to tackle agricultural market challenges.
- Market Positioning and Investment: Corteva plans to make targeted investments to support growth and leverage its first-mover advantage in nature-inspired technologies, pursuing opportunities that promise attractive returns in differentiated markets, thereby enhancing its competitive position.
- Forward-Looking Statement Risks: Corteva's forward-looking statements highlight various risks associated with the separation process, including potential distractions for management and possible litigation, which could impact the company's operational results and business development, necessitating careful consideration.
See More
FMC and Corteva Forge Strategic Supply Agreement
- Strategic Partnership: FMC and Corteva's strategic supply and license agreement will expand the application of rimisoxafen technology across North and South American corn and soybean markets, significantly enhancing farmers' ability to combat herbicide-resistant weeds, particularly the Amaranthus species, which poses a major threat to soybean crops.
- Market Potential Unlocked: Corteva's initial $200 million pre-purchase payment for rimisoxafen ensures a steady supply, and the introduction of this innovative technology is expected to help farmers improve productivity and profitability, reflecting both companies' confidence in future market demand.
- Dual Mode of Action: Rimisoxafen's dual mode of action creates a significantly higher barrier to resistance development, effectively managing multiple-resistant weeds like palmer amaranth and waterhemp, which cost farmers billions in lost yields annually.
- Future Outlook: Over the next decade, FMC plans to continue developing additional rimisoxafen-based products, further solidifying its core position in global agricultural innovation while promoting rapid adoption of this technology to meet long-term farmer needs.
See More
